What was the primary endpoint of the Effasayil trial?

Featuring Brad Glick, DO, MPH | AAD Board of DirectorsProgram Director, Dermatology Residency, Larkin Health System, Palm Springs CampusAssistant Clinical Professor of Dermatology, Herbert Wertheim College of MedicineMiami, Florida | Published September 01, 2023

Loading...

Related CME

Related Media

Powered by Polaris TM